Literature DB >> 8614513

Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophy.

K N North1, G Miller, S T Iannaccone, P R Clemens, D A Chad, I Bella, T W Smith, A H Beggs, L A Specht.   

Abstract

We report four patients, currently aged 15, 17, 19, and 42 years, with X-linked dystrophinopathy who presented with mental retardation (IQ range, 60-68) and psychiatric disturbance in the absence of muscle weakness. All patients had elevated serum creatine kinase and dystrophic changes on muscle biopsy. There were alterations in the size and abundance of dystrophin on immunohistochemistry and immunoblotting in all cases, consistent with a molecular diagnosis of Becker's muscular dystrophy. Two patients had deletions of the dystrophin gene on DNA analysis. These findings suggest that Becker's muscular dystrophy may be associated with a predominantly neuropsychiatric presentation and that dystrophinopathy should be considered in the differential diagnosis of unexplained cognitive or psychiatric disturbance in males. Serum creatine kinase may provide an adequate screening test in this clinical situation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614513     DOI: 10.1212/wnl.46.2.461

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  beta-dystrobrevin, a member of the dystrophin-related protein family.

Authors:  D J Blake; R Nawrotzki; N Y Loh; D C Górecki; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

2.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

3.  The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.

Authors:  Richard Milner; Stephanie Hung; Xiaoyun Wang; Maria Spatz; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2007-11-21       Impact factor: 6.200

4.  Association of the DTNBP1 locus with schizophrenia in a U.S. population.

Authors:  Birgit Funke; Christine T Finn; Alex M Plocik; Stephen Lake; Pamela DeRosse; John M Kane; Raju Kucherlapati; Anil K Malhotra
Journal:  Am J Hum Genet       Date:  2004-09-10       Impact factor: 11.025

5.  CUGC for Duchenne muscular dystrophy (DMD).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-01-12       Impact factor: 4.246

6.  The neurocognitive profile of adults with Becker muscular dystrophy in the Netherlands.

Authors:  Zaıda Koeks; Danique M J Hellebrekers; Nienke M van de Velde; Iris Alleman; Pietro Spitali; Hermine A van Duyvenvoorde; Jan J G M Verschuuren; Jos G M Hendriksen; Erik H Niks
Journal:  J Neuromuscul Dis       Date:  2022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.